Pharmacovigilance through Clinical Observation: Case Series of Drug-Related Oral Lesions and Reactions
Main Article Content
Keywords
Pharmacovigilance, Amalgam, Adverse effects, dental materials, Dentistry
Abstract
The Pharmacovigilance Program of India (PvPI) includes a sensitization program focused on the adverse effects of not only medications but also materials used in medical and dental diagnosis and therapeutics under the Materiovigilance Program of India (MvPI). The oral cavity could be significantly affected by the adverse effects of both medicines and dental materials. Consequently, dental professionals are more involved in reporting and studying the adverse effects that occur in the oral cavity. Since many lesions caused by these adverse effects can mimic other oral conditions, it was essential to report these cases and closely monitor de-challenges and re-challenges to draw accurate conclusions. This series highlighted 15 cases of oral lesions resulting from adverse drug and material reactions that were documented at the Department of Oral Medicine. These cases were duly reported under both the PvPI and MvPI.
References
2. Almeyda J, Levantine A. Drug reactions. XVI. Lichenoid drug eruptions. Br J Dermatol. 1971;85:604–7. [PubMed: 4259599]
3. Penneys NS, Ackerman AB, Gottlieb NL. Gold dermatitis. A clinical and histopathological study. Arch Dermatol. 1974;109:372–6. [PubMed: 4273615]
4. Ditrichová D, Dobešová J, Kaprálová S, Eber M, Steigerová H. Nejčastější kontaktní alergeny ústní dutiny a rtů. Čes Stomat 2007; 107:39–45.
5. Minciullo, P. L., Paolino, G., Vacca, M., Gangemi, S., & Nettis, E. (2016). Unmet diagnostic needs in contact oral mucosal allergies. Clinical and Molecular Allergy, 14, 10.
6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 Aug;30(2):239-45.
7. The use of the WHO–UMC system for standardised case causality assessment. Accessed from: http://www.WHO-UMC.org/graphics/4409.pdf.
8. Rietschel RL, Fowler JF Jr. Fisher´s contact dermatitis. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
9. Benáková N, Štork J. Lichen planus a lichenoidní reakce. Čes-slov Derm 2005; 80:65–75.
10. Hougeir FG, Yiannias JA, Hinni ML, Hentz JG, el-Azhary RA. Oral metal contact allergy: a pilot study on the cause of oral squa mous cell carcinoma. Int J Dermatol 2006; 45:265–71.
11. Zaccara, G., Franciotta, D., & Perucca, E. (2007). Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia, 48(7), 1223-1244.
12. Ismail SB, Kumar SKS, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007; 49:89–106.
13. Laxenaire MC, Mertes PM; Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth. 2001 Oct;87(4):549-58. doi: 10.1093/bja/87.4.549. PMID: 11878723.
14. Campos L, Galvão VR, Kalil J, Castells M, Giavina-Bianchi P. BAT in the Diagnosis of Drug Allergy: a Novel Tool in Clinical Daily Practice? Curr Allergy Asthma Rep. 2019;19(4):20.
15. Andrei M, Tovaru S, Parlatescu I, Gheorghe C, Pirvu C. Correla-tion of corrosion resistance of dental alloy restorations with oral li-chen planus pathology. Materials and Corrosion. 2016;67(8):882-7
16. Sarkar R, Kaur C, Kanwar AJ. Extensive fixed drug eruptions to nimesulide with cross reactivity to sulphonamide in a child. Pediatr Dermatol 2002;19:553-4.
17. Corderio MR, Gonacalo M, Fernandes B, Oliveira H, Figuedo A. Positive lesional patch tests in fixed drug eruption from nimesulide. Contact Dermatitis 2000;43:307.
18. Kumaran S, Sandhu K, Saikia UN, Handa S. Nimesulide induced bullous fixed drug eruption of the labial mucosa. Indian J Dermatol Venereol Leprol January-February 2004 Vol 70 Issue 1
19. Sarkar R, Kaur C, Kanwar AJ. Extensive fixed drug eruptions to nimesulide with cross reactivity to sulphonamide in a child. Pediatr Dermatol 2002;19:553-4
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.